Drug-repurposing screen on patient-derived organoids identifies therapy-induced vulnerability in KRAS-mutant colon cancer
Cell Rep | April 2023
October 11, 2023
Cell Rep | April 2023
July 20, 2023
Eur J Pharm Sci | July 2023
February 17, 2022
eLife | July 2021
February 17, 2022
J Cyst Fibros | May 2021
February 17, 2022
J Vis Exp | July 2021
February 16, 2022
Cell | May 2015
February 16, 2022
Nature | May 2009
February 16, 2022
Gastroenterology | Nov 2011
February 16, 2022
eLife | Nov 2016
February 16, 2022
Cell | Jan 2018